Our Doctors
- Featured Doctors in Popular Specialties.... ........ Read more
Current Projects
- Cytological grading of CA breast on FNAC and its correlation with histological grading. Correlation of HER2 / (Cerb B2) grading on IHC with results of FISH on 2+ positive cases of infiltrating carcinoma. - Dr. Sumedha Kotwal
- Correlation of HER2 / (Cerb B2) grading on IHC with results of FISH on 2+ positive cases of infiltrating carcinoma. - Dr. Sumedha Kotwal
- Phase III multinational multicentric randomized trials of hematopoetic factors in metastatic carcinoma breast. - Dr. Meenu Walia
- Phase III multinational multicentric randomized trials of newer supportive therapies to prevent oral ulcers in patients undergoing chemotherapy. - Dr. Meenu Walia
- Phase II multinational multicentric trials of lepatanib in advanced carcinoma cervix. - Dr. Praveen Bansal
- A randomized active control double blind, double dummy parallel group multinational study to assess the efficacy, tolerability and safety of newer anti-emetics Granisetron Transdermal Delivery System (GTDS) in Chemotherapy-induced Nausea and Vomiting (CINU) associated with the administration of moderately of highly emetogenic multiday chemotherapy. - Dr. Meenu Walia
- Post marketing surveillance study of GnRH agonists in the treatment of advanced prostate cancer (Phase IV Study). - Dr. Meenu Walia
- Efficacy and safety of XMO1 compared to placebo in patients with solid tumors or non-myeloid haematological tumours receiving non-platinum chemotherapy A multinational, multi-center, randomized, placebo-controlled double blind parallel group phase - III study. - Dr. Meenu Walia
- Role of intensity modulated radiation in head and neck cancers - Dharamshila's experience. - Dr. Sandeep Agarwal
- Evaluation of 2 DG as a radio modifier in treatment of glioblastoma multiforme. - Dr. Dinesh
- Evaluation of efficacy and tolerability of capecitabine as a radio sensitizer in squamous cell carcinoma of head and neck. - Dr. Dinesh
- Optimizing cancer radiotherapy with 2 DG dose escalation studies in patients with GBM. - Dr. Dinesh
- Airway assessment and management in head and neck cancer patients. - Dr. Neha
- Molecular analysis of FHIT gene and P16 and their association with HPV in Indian head and neck carcinoma patients. - Dr. Pawan
- Analysis of genetic polymorpheris of P73 and P53 and the risk of cancers in Indian patients. - Dr. Pawan
- Study of P53 mutations identification of hyploid sub and type of P53 in sporadic breast cancers. - Dr. Pawan
- Molecular study of candidate genes on chromosome 16 in sporadic breast cancers. - Dr. Pawan
- Study of BRCA-1 and BRCA-2 genes expression in human breast cancer cells.
- Transcription factors AP-1 and NF-kB in breast carcinomas.
- Methylation and expression of FHIT gene in Indian female breast cancer patients.
- An open label multicentric study to assess the efficacy and safety of recombinant human granulocyte colony stimulating factor (filgratism) injection in patients undergoing myelosuppressive chemotherapy. - Dr. Meenu Walia and Dr. Praveen Bansal
- An open label multicentric study to assess the efficacy and safety of pegylated form of recombinant human granulocyte colony stimulating factor (pegfilgratism) injection in patients undergoing myelosuppressive chemotherapy. - Dr. Meenu Walia and Dr. Praveen Bansal
- Phase ½ modified dose escalation, open label trial to detemnie the therapeutic effect and safety of INCB007839 combined with trastuzumab in patients with previously untreated HER2 positive metastatic breast cancer. - Dr. Meenu Walia
- Phase III randomized, double-blind, active controlled, parallel-group study, conducted under in-house blinding conditions, to examine the safety, tolerability and efficacy of single dose of intravenous MK-0517 for the prevention of CINV associated with cisplatin chemotherapy. - Dr. Meenu Walia
Follow us on